DarioHealth, a digital chronic-condition management platform, has announced a new partnership with a national Medicare Advantage health plan, aiming to launch its behavioral health initiative, Twill by Dario, for the plan’s members starting January 2025.
The Dario platform offers data analytics and personalized coaching for various health conditions, including diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. This collaboration represents DarioHealth’s first national health plan contract in the Medicare Advantage sector.
In February, DarioHealth acquired Twill, a digital therapeutics company, with an investment of $22.4 million in equity financing. Recently, DarioHealth integrated Twill’s condition-specific communities and peer groups into its cardiometabolic platform, enhancing its support for users.
The company anticipates that the multimillion-dollar Medicare Advantage contract will significantly boost its annual recurring revenue growth within the B2B2C channel in 2025. With this new agreement, DarioHealth now has four national health plan contracts, bringing its total to seven health plans overall.
“Before the acquisition of Twill, approximately 30% of seniors using the Dario platform were in this demographic, a number we expect to increase with this partnership,” said Steven Nelson, Chief Commercial Officer at DarioHealth. He emphasized the need to address the high comorbidity rates between metabolic and mental health conditions, which Dario is well-prepared to tackle through tailored solutions.
Nelson also noted that the addition of another national health plan will facilitate revenue expansion while enabling the implementation of enhanced enrollment and engagement technologies across a broader member base.
Industry Context
In August, DarioHealth reported total revenue of $6.26 million for Q2 2024, marking a 1.7% increase compared to Q2 2023, largely driven by B2B2C revenues. Additionally, the company’s commercial and consumer revenues reached $7.34 million—an impressive 105% increase from $3.57 million in the same quarter of the previous year, prior to a non-recurring price concession with a pharmaceutical partner.
Last year, DarioHealth strengthened its leadership team by appointing Eitan Shay as the company’s product officer and Arnaud Robert as a strategic advisor to CEO Erez Raphael. Shay has held senior positions at Livongo, Teladoc, and Meta, while Robert has extensive experience as the former Executive Vice President and Chief Digital Officer at Sanofi, with prior roles at Microsoft, Nike, Disney, and Viking Cruise Lines.
DarioHealth also partnered with Amwell last year to integrate a cardiometabolic program into its digital offerings. Patients receiving care from clinicians using Amwell’s telehealth platform can be referred to Dario’s program for chronic conditions such as diabetes, high blood pressure, and weight management. The program employs connected devices—including glucometers, scales, and blood pressure monitors—alongside data tracking and support from health coaches to enhance patient care.
Related topics:
